Moderna Inc (MRNA)

Life is short. Time relentlessly moves forward, transforming seconds and minutes into hours and days. Before you know it, it’s nearly the end of 2023…

Don’t Let the Q3 Earnings Miss Keep You From These 3 Stocks!

By Will Ashworth, InvestorPlace Contributor Nov 20, 2023

Few S&P 500 companies didn’t meet or exceed Q3 2023 earnings estimates. Here are three earnings miss investment opportunities.

6 Nasdaq 100 Stocks Down 40% or More that Will Soar As Much 367%

By Rich Duprey, InvestorPlace Contributor Nov 8, 2023

Wall Street is forever optimistic about the future for stocks and pegs these seven Nasdaq 100 stocks as ready for supersonic growth.

High Risk Alert: 7 Vulnerable Stocks to Dump Now

By Ian Bezek, InvestorPlace Contributor Nov 7, 2023

The economy is showing weakness. These seven stocks at risk could be at the center of the coming bust.

3 Healthcare Stocks to Invest in for a Big Shot of Gains

By Joel Baglole, InvestorPlace Contributor Oct 23, 2023

Most healthcare stocks are down across the board. Pharma companies, health insurers, and medical device manufacturers have all seen their share prices decline. That said, there are a few stocks that have managed to separate themselves from the pack with new innovations and strong financial results.

3 Stocks That Are Dead in the Water

By Ian Bezek, InvestorPlace Contributor Oct 19, 2023

These three stocks to avoid once had promising futures, but their best moments are now behind them.

Don’t Hold On: 7 Stocks to Sell Before 2024

By Thomas Niel, InvestorPlace Contributor Oct 15, 2023

Consider it best to jettison these seven stocks to sell from your portfolio, between now and the end of 2023.

3 Stocks That Are Down Big, But Are Due to Fall Much Further

By Chris MacDonald, InvestorPlace Contributor Oct 12, 2023

While the search for falling stocks is an easy one, these are the ones that might not get up from the mat.

3 Shaky Stocks to Sell in October Before It’s Too Late

By Chris MacDonald, InvestorPlace Contributor Oct 9, 2023

Indeed, bearish reasons prevail. If any sort of shock hits the market, I would argue that valuations aren't positioned to absorb any sort of hit. Thus, the market is priced for basically a soft landing currently.

Don’t Miss the Boom: 3 Healthcare Stocks Set to Explode Higher

By Joel Baglole, InvestorPlace Contributor Sep 26, 2023

For these reasons, the healthcare sector is a long-term, growth opportunity for investors. In fact, all segments are forecast to experience growth over the next 15 to 20 years.

Beware! 3 Healthcare Stocks Waving Massive Red Flags Right Now.

By Alex Sirois, InvestorPlace Contributor Sep 24, 2023

These three healthcare stocks to sell are waving red flags at investors who should pay attention or suffer the consequences.

Beware! 3 Biotech Stocks Waving Massive Red Flags Right Now

By Alex Sirois, InvestorPlace Contributor Sep 20, 2023

There are always many biotech stocks to avoid and these firms are among the clearest choices currently to steer clear of.

Beware! 3 Value Stocks Waving Massive Red Flags Right Now.

By Jeremy Flint, InvestorPlace Contributor Sep 20, 2023

Traps are omnipresent today. Don't fall for low ratios and cheap stats, but look for underlying potential. Heed these value stocks to avoid.

Beware! 3 Nasdaq Stocks Waving Massive Red Flags Right Now.

By Joel Baglole, InvestorPlace Contributor Sep 20, 2023

A range of worries are pulling these Nasdaq stocks to sell lower and clouding the outlook for their share prices.

3 Stocks to Avoid Like the Plague Right Now: MRNA, GPS, PTON

By Ian Bezek, InvestorPlace Contributor Sep 19, 2023

The good economic times of the past few years appear to be ending. As such, it's time to exit these three stocks to avoid.

The 7 Best Meme Stocks to Buy Now: September 2023

By Thomas Niel, InvestorPlace Contributor Sep 14, 2023

Let's take a look at seven past and present favorites of the Reddit set, each of which should be considered one of the best meme stocks to buy right now.

Flu Vaccine Results Give Moderna (MRNA) Stock a Shot in the Arm

By Josh Enomoto, InvestorPlace Contributor Sep 13, 2023

Moderna released encouraging results for its late-stage trial of its flu vaccine. Now, MRNA stock is looking like more than a one-trick pony.

The 3 Most Undervalued Biotech Stocks to Buy in September 2023

By Joel Baglole, InvestorPlace Contributor Sep 12, 2023

While these undervalued biotech stocks have struggled of late, they could surprise investors and prove to be long-term winners.

3 Meme Stocks That Could Actually Rebound in Q4

By Josh Enomoto, InvestorPlace Contributor Sep 9, 2023

With meme stocks benefiting from a sector-wide resurgence, these are the compelling wagers you may want to consider.

7 Biotech Stocks to Sell in September Before They Crash & Burn

By Alex Sirois, InvestorPlace Contributor Sep 6, 2023

Biotech stocks to sell are a dime a dozen and very risky which is why September is a great time to offload them.

Moderna Inc (MRNA)

Don’t Waste Another Minute: Dump These 3 F-Rated Stocks Now

3 S&P 500 Stocks That Are About to Get Absolutely Crushed

MRNA Stock Surges as Moderna Teams Up With Merck to Fight Cancer

Why Is Moderna (MRNA) Stock Up 11% Today?

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Moderna Inc (MRNA)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

MRNA Stock Predictions, Articles, and Moderna Inc News

Subscriber Sign in